C4 Therapeutics sets cemsidomide trial timelines through 2028

Go back to C4 Therapeutics sets cemsidomide trial timelines through 2028
Cache Capital Corp. (NASDAQ: CCCC) Delayed: 3.76 --0 (-0%)
Previous Close $3.76    52 Week High $0.30 
Open $3.76    52 Week Low $0.30 
Day High $3.76    P/E N/A 
Day Low $3.76    EPS $0.00 
Volume 829